 Health Care |
Health Care |
|
|
Vulnerable Republicans call for ACA enhanced subsidy extension |
Republicans say they won't negotiate on extending ObamaCare's enhanced subsidies. But there's at least some signs of growing GOP discomfort over the apparent lack of a plan. |
Associated Press/Alex Brandon |
A group of 13 vulnerable House Republicans on Tuesday sent a letter to Speaker Mike Johnson (R-La.) urging him to "immediately" move to extend the subsidies once the government reopens.
"Our Conference and President Trump have been clear that we will not take healthcare away from families who depend on it. This is our opportunity to demonstrate that commitment through action," the lawmakers, led by Reps. Jeff Van Drew (R-N.J.) and Jen Kiggans (R-Va.), wrote.
There are also some internal discussions happening among Senate Republicans on a subsidy plan, though the lawmakers involved have also been adamant they will not negotiate with Democrats until the government reopens.
The government has been shut for three weeks, and both sides appear dug in.
Democrats are withholding support for a stopgap spending bill and are seeking negotiations and assurances on the expiring subsidies and other spending and appropriation issues. Republicans say they will refuse to negotiate on health care matters until Democrats vote to reopen the government.
The House letter rejected the Democratic demand that a tax credit extension be tied to the government shutdown but urged Johnson to "chart a conservative path that protects working families in our districts across the country."
The fact that House Republicans are calling for an extension of the subsidies is notable, as many hardline conservatives remain outright opposed to any extension at all — a path that Republican pollsters and allies of President Trump say would be a mistake heading into the midterm elections.
Consumers with 2026 ACA marketplace plans are already seeing substantially higher premiums as state and federal "window shopping" allows people to see the costs of their plans ahead of the Nov. 1 start of open enrollment. Insurers are anticipating the enhanced subsidies will expire and are pricing their coverage accordingly. |
Welcome to The Hill's Health Care newsletter, we're Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health. |
|
| How policy will be impacting the health care sector this week and beyond: |
|
|
Tylenol maker Kenvue is calling on the Food and Drug Administration (FDA) to back off a proposed safety label change to acetaminophen after the Trump administration linked its use during pregnancy to autism. In response to a citizen petition filed last month, the company said the "expansive scientific evidence developed over many years" does not support a causal link between acetaminophen use in pregnancy and developmental … |
| |
|
A majority of U.S. adults express a high level of concern about their health care costs increasing over the next year, according to a survey released Tuesday. The Associated Press-NORC poll, conducted in mid-October, shows nearly 6 in 10 respondents are "extremely" or "very" concerned about rising health care costs this coming year — at 32 percent and 25 percent, respectively. Another 26 percent said they're "somewhat" concerned, … |
| |
|
Upcoming news themes and events we're watching: |
- The Senate HELP Committee holds a hearing Thursday on the 340B drug discount program
|
|
|
Branch out with a different read: |
|
|
Biden finishes radiation treatment for cancer, rings the bell at Penn Medicine |
Former President Biden on Monday finished a round of radiation therapy to treat his aggressive former of prostate cancer, according to a Biden spokesperson. The course lasted several weeks, and the former president is "doing well," the spokesperson told The Hill's sister network, NewsNation. She did not comment on whether Biden's medical team thinks he will need any additional rounds of radiation treatment. Biden rang the ceremonial … |
|
|
Local and state headlines on health care: |
|
|
Health news we've flagged from other outlets: |
- Anti-malaria funding cuts could lead to 'deadliest resurgence ever,' study warns (The Guardian)
- Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs (Stat)
- 'Cancer doesn't care': Citizen lobbyists unite to push past Washington's ugly politics (KFF Health News)
|
|
|
Opinions related to health submitted to The Hill: |
|
|
You're all caught up. See you tomorrow! |
400 N Capitol Street NW Suite 650, Washington, DC 20001 |
Copyright © 1998 - 2025 Nexstar Media Inc. | All Rights Reserved. |
|
|
|
If you believe this has been sent to you in error, please safely unsubscribe.
No comments:
Post a Comment